#USA #Houston #financial results #Nutex Health #NASDAQ NUTX

Nutex Health Reports Surging Revenue and Profits in Third Quarter 2025

Nutex Health Inc., a leading healthcare management company based in Houston, Texas, has recently published its financial results for the third quarter ending on September 30, 2025. The report reveals a staggering 225.5% increase in total revenue compared to the same period last year, showcasing the company's robust growth trajectory.

Financial Highlights

For the first nine months of 2025, Nutex Health achieved total revenue of $723.6 million, a substantial jump from $222.3 million during the same timeframe in 2024. This impressive rise in revenue can largely be attributed to the performance of its hospital division, which generated around $700.5 million, reflecting a 251.4% increase from the previous year.

The company reported an attributable net income of $59.0 million for the first three quarters of 2025, a significant recovery from the $9.5 million net loss recorded in the previous year. Consequently, diluted earnings per share surged from a loss of $1.91 to a profit of $8.87.

Growth Drivers

A detailed examination reveals that approximately 66.1% of the hospital revenue stemmed from increased claims and successful outcomes in the Independent Dispute Resolution (IDR) process, an initiative aimed at addressing underpayments from payors. The hospital division reported handling between 60-70% of the visits through IDR, achieving a legal determination win rate of over 85% on submitted claims. As a result, Nutex Health maintained a collection rate of over 80% on these victories.

Operating income saw a remarkable improvement, climbing to $244.7 million, compared to $16.4 million in 2024, showcasing the efficiency of Nutex Health's operational management. Furthermore, EBITDA witnessed an extraordinary rise from $19.9 million to $142.9 million, marking a 616.4% increase.

Stock-Based Compensation and Operating Activities

The stock-based compensation expense for the nine months ended September 30, 2025, was $119.6 million, a rise from $2.0 million in the same period last year. This increase is primarily due to obligations related to hospitals still under construction or ramping operations, suggesting a commitment to expanding capacity in line with growing demand for healthcare services.

During this period, Nutex Health's total visits at the hospital division increased notably, reaching 140,074, compared to 122,944 for the previous year, reflecting a 13.9% increase. This uptrend indicates a rising demand and utilization of healthcare facilities within their network.

Future Outlook

In light of these outstanding figures, CEO Dr. Tom Vo expressed optimism about the future, emphasizing the new growth strategies being employed to expand operations further. As the company continues to navigate the post-pandemic landscape, the strong financial position, coupled with record cash reserves of $166.0 million, positions Nutex Health well for future investments and initiatives.

In tandem with these results, on November 19, 2025, Nutex Health received confirmation from Nasdaq that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) following the filing of Form 10-Q for the period ending June 30, 2025. This compliance speaks to the company's commitment to transparency and governance.

Moving forward, Nutex Health will host a conference call on December 2, 2025, to discuss its restated fiscal year 2024 results and Q3 2025 outcomes, reiterating its goal of pulling stakeholders into its journey of growth and transformation in the healthcare sector.

Conclusion

Nutex Health's financial achievements in 2025 underscore the effectiveness of their healthcare delivery model, as they adapt to the evolving demands of the healthcare landscape. With an eye on sustainable growth, they are positioned to make significant strides in expanding their network and enhancing patient care across their facilities nationwide.